Frans Opdam

Frans Opdam started as a pharmacist and has always been interested in the mechanism of action of anti-cancer drugs. His knowledge comes in handy in both his position as a medical oncologist – clinical pharmacologist and principal investigator in several phase I studies.

In addition to his clinical work, Frans Opdam was a Clinical Assessor for the Medicines Evaluation Board of the European Medicines Agency and has experience with regulations within the EMA.

His knowledge and interests lie in the field of targeted therapies in oncology, mechanisms of drug resistance, dose-determining studies, drug interactions and ADME studies. He currently holds a position as principal investigator within the Cancer Core Europe network.

Frans Opdam indicates that his challenge is to research and offer new treatment modalities to all patients and to bring science one step closer to curing cancer.

• Gynecological cancers
• Drug interaction studies
• Mechanisms of drug resistance
• Therapeutic Drug Monitoring

• Principal investigator at the Cancer Core Europe network